Optellum, Mirada present lung cancer study at RSNA 2017

Artificial intelligence (AI) software developer Optellum and imaging software...Read more on AuntMinnie.comRelated Reading: Mirada's deep-learning contours match human-drawn contours Optellum unveils lung cancer analysis software Mirada showcases XD:PACS at RSNA 2016 Philips, Mirada sign distribution deal Mirada launches nuclear medicine software at RSNA 2015 Former Philips CEO joins Mirada Medical
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

ConclusionA diagnosis of LC following LTx remains rare. LC in the explanted lung seems to have no impact on survival for early ‐stage disease. LC in the transplanted or native remaining lung after LTx has poor prognosis.This article is protected by copyright. All rights reserved.
Source: Clinical Transplantation - Category: Transplant Surgery Authors: Tags: Original Article Source Type: research
Radiologists from across Canada will come together on November 5 and 6 to meet...Read more on AuntMinnie.comRelated Reading: Canadian group tackles MRI waits through scheduling CAR publishes white paper on artificial intelligence How IT innovation can improve healthcare in Canada Report tallies growth in imaging scanners in Canada Canadian guidelines support CT lung cancer screening
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
Lung cancer is the most frequent type of cancer across genders and the most common reason for cancer-related death worldwide [1]. Hybrid positron emission tomography/computed tomography (PET/CT) using 18F-fluorodeoxyglucose (FDG) is an established imaging method for the staging of patients with lung cancer [2]. Recently, the use of artificial intelligence and more specifically deep learning has produced promising results in various applications in medicine, including automated skin cancer detection [3] or automated Alzheimer disease detection based on FDG-PET data [4].
Source: Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research
ConclusionsMost recurrences occur within two years after transplantation and are the cause of death in these patients. Patients with nodal disease tend to have higher recurrence rates. Multidisciplinary review of abnormal pre-transplant radiographic findings and close follow up may allow for detection of undiagnosed cancers.
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
In this study, we produced synthetic and natural microparticles (MPs) based on poly(dl‑lactide‑co‑glycolide) (PLGA) or gellan gum through tailored water/oil emulsion procedures. Morphological and physico-chemical characterizations were carried out on both classes of MPs showing particles having diameters within suitable ranges to reach the CF airways. In vitro biocompatibility tests were also performed on both MPs using a human lung cancer cell line (A549) demonstrating that treatment with MPs induces no cytotoxic effects. Both classes of MPs were loaded with a mucolytic agent (N‑acetyl cysteine, NAC) and their rel...
Source: Materials Science and Engineering: C - Category: Materials Science Source Type: research
Authors: Parashar P, Tripathi CB, Arya M, Kanoujia J, Singh M, Yadav A, Kumar A, Guleria A, Saraf SA Abstract Co-therapy through biotin modified nanoparticles (NPs) of gefitinib (Gnb) and naringenin (Nar) was investigated for its therapeutic and synergistic potential against lung cancer. The biotin-conjugated polymeric NPs (bty-Nar/Gnb) were developed using oil in water emulsion technique and optimized using central composite design. The formulations were subjected to various in vitro (A549 cell lines) and in vivo evaluations in urethane-induced lung cancer. Co-administration of Gnb and Nar NPs displayed a signific...
Source: Artificial Cells, Nanomedicine and Biotechnology - Category: Biotechnology Tags: Artif Cells Nanomed Biotechnol Source Type: research
.
Source: Artificial Cells, Blood Substitutes, and Biotechnology - Category: Biotechnology Authors: Source Type: research
Development of T-cell based immunotherapies for the treatment of various cancers has been challenged for decades by the lack of target antigens that are only expressed by cancer cells and not normal tissues. KK-LC-1 belongs to a family of tumor antigens known as cancer-testis antigens, which have restricted expression in immune-privileged germ cells and various cancers, and not in normal life-essential tissues. This makes KK-LC-1 an attractive target for T-cell based anti-cancer therapies.Inventors from the National Cancer Institute ’sExperimental Transplantation and Immunology Branch (NCI ETIB) have discovered two n...
Source: NIH OTT Licensing Opportunities - Category: Research Authors: Source Type: research
ConclusionIn our setting, excluding NMSC, the incidence is 8.8 times greater than estimations for the general population, with a high rate of lung cancer, so we should implement preventive and diagnostic strategies.ResumenIntroducciónLa mayor supervivencia del paciente trasplantado viene acompañada del aumento en la tasa de tumores de novo (TN) que representan la complicación tardía más frecuente. Podemos distinguir entre tumores de piel no melanoma (TPNM), síndrome linfoproliferativo postrasplante (SLPT) y tumores de órgano sólido (TOS). Nuestro objetivo es determina...
Source: Cirugia Espanola - Category: Surgery Source Type: research
CONCLUSION: The findings of this study indicated that combined application of natural products in nanocarriers could offer attractive therapeutic options. PMID: 30307334 [PubMed - as supplied by publisher]
Source: Artificial Cells, Nanomedicine and Biotechnology - Category: Biotechnology Tags: Artif Cells Nanomed Biotechnol Source Type: research
More News: Cancer | Cancer & Oncology | Learning | Lung Cancer | Lung Transplant | Nuclear Medicine | Radiology | Study | Universities & Medical Training